Company Filing History:
Years Active: 2009
Title: Innovator Spotlight: Jessica Laggerbauer's Contributions to Biochemistry
Introduction: Jessica Laggerbauer is an accomplished inventor based in Munich, Germany. With a keen focus on biochemistry, she has made significant strides in the field through her innovative work. Her research specializes in developing advanced enzyme variants that hold promise for various applications in glucose detection.
Latest Patents: Jessica holds one notable patent titled "Genetically Engineered Pyrroloquinoline Quinone Dependent Glucose Dehydrogenase Comprising an Amino Acid Insertion." This invention pertains to enhanced versions of soluble pyrroloquinoline quinone (PQQ)-dependent glucose dehydrogenases, which include an amino acid insertion between positions 428 and 429. The patented technology improves substrate specificity for glucose, making it invaluable for accurately determining sugar concentrations in samples, particularly glucose.
Career Highlights: Jessica is currently employed at Roche Diagnostics Operations, Inc., a leading company in the field of diagnostics. Her work at Roche reflects her commitment to advancing healthcare solutions through innovative biochemical technologies.
Collaborations: Throughout her career, Jessica has collaborated with notable colleagues such as Mara Boenitz-Dulat and Rainer Schmuck. These collaborations have allowed them to pool their expertise and drive forward their shared vision of improving enzyme applications in medical diagnostics.
Conclusion: As a pioneering inventor, Jessica Laggerbauer exemplifies the spirit of scientific innovation. Her work on glucose dehydrogenase variants not only represents a significant patent in biochemistry but also contributes to advancements in medical diagnostics, showcasing the impact of her research on real-world applications.